Back
Blueprint Medicines Vs. Matthews International Industry Stock Comparison
Sell
37
BPMC
Blueprint Medicines
Last Price:
94.25
Seasonality Move:
5.92%
Buy
66
MATW
Matthews International
Last Price:
30.85
Seasonality Move:
1.52%
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
- The current Blueprint Medicines [BPMC] share price is $94.15. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
66
Matthews International (MATW)
is a Buy
Is Matthews International a Buy, Sell or Hold?
- The current Matthews International [MATW] share price is $30.84. The Score for MATW is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- MATW is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $94.15
The current trend is moderately bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
MATW Stock Price Chart
What is Matthews International's stock price today?
-
The Matthews International share price today is $30.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MATW is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 52.43 | Buy |
| Chaikin Money Flow: | -650985 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.74 - 97.86) | Buy |
| Bollinger Bands (100): | (85.66 - 106.02) | Sell |
MATW Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 84.93 | Buy |
| Chaikin Money Flow: | 345410 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.28 - 25.54) | Buy |
| Bollinger Bands (100): | (22.55 - 26.39) | Buy |
BPMC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.95 | Buy |
| 20-day SMA: | 93.65 | Buy |
| 50-day SMA: | 90.42 | Buy |
| 200-day SMA: | 96.05 | Sell |
| 8-day EMA: | 94.56 | Sell |
| 20-day EMA: | 93.49 | Buy |
| 50-day EMA: | 92.48 | Buy |
| 200-day EMA: | 91.19 | Buy |
MATW Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.94 | Buy |
| 20-day SMA: | 24.26 | Buy |
| 50-day SMA: | 23.29 | Buy |
| 200-day SMA: | 26.19 | Buy |
| 8-day EMA: | 25.74 | Buy |
| 20-day EMA: | 24.52 | Buy |
| 50-day EMA: | 23.98 | Buy |
| 200-day EMA: | 26.71 | Buy |
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.
Matthews International Earnings Growth & MATW Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.28 per share.
Blueprint Medicines Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Matthews International Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||